Jennifer McMahon joined the Seroba team in 2011. She graduated from UCD with an honours degree in Pharmacology in 2010. Jennifer then entered a masters degree programme in Biotechnology and Business to further her interest in the interface of biomedical science with commercialisation.
Having placed first in her masters degree in 2011, Jennifer then joined Seroba’s Investment Team as an Investment Analyst and was appointed Senior Analyst in 2014, Associate in 2016 and Senior Associate in 2017. Jennifer sits on the boards of Biosensia and Endotronix.